Squarepoint Ops LLC Aeglea Bio Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $282,133 - $395,067	-40,190 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $9,022 - $12,931	1,386 Added 3.57%	40,190 $285,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $60,314 - $166,052	15,041 Added 63.3%	38,804 $359,000
Q1 2020 May 15, 2020	SELL	$3.51 - $8.48 $85,851 - $207,412	-24,459 Reduced 50.72%	23,763 $111,000
Q4 2019 Feb 14, 2020	SELL	$7.23 - $8.55 $163,679 - $193,563	-22,639 Reduced 31.95%	48,222 $368,000
Q3 2019 Nov 14, 2019	BUY	$6.42 - $9.0 $115,540 - $161,973	17,997 Added 34.04%	70,861 $545,000
Q2 2019 Aug 14, 2019	BUY	$6.1 - $8.78 $86,083 - $123,903	14,112 Added 36.42%	52,864 $362,000
Q1 2019 May 15, 2019	SELL	$7.6 - $9.4 $157,251 - $194,495	-20,691 Reduced 34.81%	38,752 $312,000
Q4 2018 Feb 14, 2019	SELL	$6.51 - $10.19 $78,491 - $122,860	-12,057 Reduced 16.86%	59,443 $445,000
Q3 2018 Nov 14, 2018	BUY	$8.24 - $11.0 $316,350 - $422,312	38,392 Added 115.96%	71,500 $684,000
Q2 2018 Aug 14, 2018	BUY	$7.87 - $10.89 $177,137 - $245,112	22,508 Added 212.34%	33,108 $350,000
Q1 2018 May 15, 2018	BUY	$5.07 - $10.9 $53,742 - $115,540	10,600 New	10,600 $105,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.